Monday 3/30 Insider Buying Report: ABBV, NKE

Monday 3/30 Insider Buying Report: ABBV, NKE

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned dollars to make a purchase, is that they expect to make money.

Today we look at two noteworthy recent insider buys.

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned dollars to make a purchase, is that they expect to make money.

Today we look at two noteworthy recent insider buys.

At AbbVie, a filing with the SEC revealed that on Monday, VP, Controller Brian L.

Durkin purchased 3,750 shares of ABBV, for a cost of $68.20 each, for a total investment of $255,755.

So far Durkin is in the green, up about 11.8% on their purchase based on today's trading high of $76.24.

AbbVie is trading up about 3.1% on the day Monday.

Before this latest buy, Durkin made one other purchase in the past year, buying $255,755 shares at a cost of $68.20 a piece.

And at Nike, there was insider buying on Thursday, by Director John W.

Rogers Jr. who purchased 2,500 shares for a cost of $84.22 each, for a total investment of $210,543.

This buy marks the first one filed by Rogers Jr. in the past twelve months.

Nike is trading up about 1.8% on the day Monday.